The starting dose of 1 mg is higher in absolute terms than semaglutide starting dose, but the relative potency is comparable
GLP-1s, in any dosage, can interact with other medications, such as blood thinners and hormonal birth control
This imbalance leads to melanin overproduction, dark spots, uneven tone, and premature wrinkles
It is: Not approved for human consumption Not intended for medical or therapeutic use Restricted to qualified research environments All use must comply with applicable research regulations
The 2025 American College of Rheumatology guidelines for SLE treatment and the 2025 EULAR recommendations for lupus nephritis both acknowledge the potential role of metabolic therapies including GLP-1 medications
Childhood and adolescent obesity rates have tripled over the past four decades, and the metabolic consequences of early-onset obesity, including type 2 diabetes, fatty liver disease, and cardiovascular risk factors, are appearing at progressively younger ages
